Patterson-UTI ( PTEN) estimates cut at Credit Suisse through 2013. Domestic business remains slow. Outperform rating and new $33 price target.RadioShack ( RSH) estimates, target cut at Credit Suisse. Shares of RSH now seen reaching $13. Estimates also reduced, Company faces lower near-term demand. Neutral rating. Safeway ( SWY) rated new Neutral at JP Morgan. Valuation call, based on a $22 price target. Consensus expectations appear conservative. Sandisk ( SNDK) downgraded at Sterne Agee from Buy to Neutral. $58 price target. Company is leveraged to the move toward SSD. Tenneco ( TEN) estimates, target reduced at Jefferies. Shares of TEN now seen reaching $43. Estimates also cut, as the company is realizing lower margins. Buy rating. Varian Medical Systems ( VAR) numbers increased at UBS. Shares of VAR now seen reaching $62. Estimates also increased on higher revenues. Neutral rating. Walt Disney ( DIS) numbers lowered at Evercore. DIS estimates were cut through 2012. Cable network and studio growth could fall short of expectations. Overweight rating and new $42 price target. Whole Foods ( WFM) rated new Neutral at JP Morgan. Valuation call, based on a $76 price target.
NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS AmeriGroup ( AGP) estimates, target raised at Oppenheimer. Shares of AGP now seen reaching $66. Estimates also increased, to match the company's new guidance. Outperform rating. Arch Coal ( ACI) estimates, target boosted at Sterne Agee. Shares of ACI now seen reaching $25. Estimates also upped, given higher met coal pricing. Neutral rating. Avnet ( AVT) estimates, target upped at Credit Suisse. Shares of AVT now seen reaching $34. Estimates also boosted, to match the company's new guidance. Neutral rating. BE Aerospace ( BEAV) numbers upped at Oppenheimer. BEAV estimates were boosted through 2012. Company's backlog is building. Outperform rating and new $43 price target. Biogen ( BIIB) numbers increased at UBS. Shares of BIIB now seen reaching $132. Estimates also increased on solid 3Q performance in core products and upside from pipeline. Broadcom ( BRCM) upgraded at JMP. BRCM was upgraded from Market Perform to Market Outperform. $42 price target. Industry checks point towards ongoing market share dominance. Cablevision Systems ( CVC) estimates, target lowered at UBS. Shares of CVC now seen reaching $16. Estimates also lowered as EBITDA growth turns negative and revenue growth slows. Neutral rating. Carter's ( CRI) downgraded at Sterne Agee from Buy to Neutral. $43 price target. Valuation call. Chevron ( CVX) downgraded at BofA Merrill from Buy to Neutral. $127 price target. Production stalls, capex risked higher. Chevron estimates increased at Jefferies. CVX estimates were raised through 2012. Company is leveraged to higher energy prices. Buy rating and $120 price target. Cigna ( CI) estimates, target increased at Oppenheimer. CI estimates were raised through 2012. HS acquisition should add to earnings. Outperform rating and new $58 price target. Cisco Systems ( CSCO) numbers upped at Oppenheimer. CSCO estimates were boosted through 2013. Channel checks show solid business momentum. Outperform rating and new $21 price target. Colgate-Palmolive ( CL) estimates reduced at Jefferies through 2012. Currency and margins are hurting earnings. Hold rating and $92 price target. Commercial Metals ( CMC) numbers lowered at Jefferies. CMC estimates were cut through 2012. Earnings recovery may take longer than expected. Hold rating and new $14 price target. Complete Production Services ( CPX) downgraded at Canaccord from Buy to Hold. $33 price target. Investors can get better annualized returns in other completion names.
Commvault ( CVLT) estimates, target boosted at ThinkEquity. Shares of CVLT now seen reaching $50. Estimates also upped, as the company is gaining market share. Buy rating. Constellation Energy ( CEG) estimates increased at UBS through 2012. Wholesale margins show some improvement. Maintain $42 price target and Neutral rating. Esterline ( ESL) downgraded at Credit Suisse from Outperform to Neutral. $67 price target. Company lacks near-term catalysts. FirstEnergy ( FE) rated new Neutral at UBS. $47 price target. Retail strategy should offset merchant decline, continued growth into '12. First Solar ( FSLR) numbers cut at ThinkEquity. Shares of FSLR now seen reaching $57. Estimates also lowered, given slower demand. Hold rating. Goodyear Tire ( GT) upgraded to hold at TheStreet Ratings. Goodyear estimates increased at UBS through 2012. $22 price target. Undervalued versus near/medium term earnings power. Maintain $22 price target and Buy rating. Hess ( HES) estimates, target boosted at Oppenheimer. HES estimates were upped through 2012. Shale development and offshore exploration are driving demand. Outperform rating. Intel ( INTC) estimates, target boosted at Credit Suisse. Shares of INTC now seen reaching $32. Estimates also upped, as emerging markets should drive growth. Outperform rating. Interpublic ( IPG) estimates, target raised at Morgan Stanley. Shares of IPG now seen reaching $12. Estimates also increased, given higher realized margins. Lamar Advertising ( LAMR) upgraded at Wedbush from Neutral to Outperform. $27 price target. Fundamentals appear to have bottomed. Lexmark ( LXK) upgraded to buy at TheStreet Ratings. Lifepoint Hospitals ( LNPT) numbers raised at Jefferies. Shares of LPNT now seen reaching $47. Estimates also increased, given cost-cutting efforts. Buy rating. McDermott ( MDR) estimates, target lowered at Keybanc. MDR estimates were cut through 2012. Company reduced its guidance. Buy rating and new $18 price target. Microsoft ( MSFT) estimates lowered at UBS through 2013. Gross margins under pressure and need to return to explicit guidance. Buy rating. Nabors Industries ( NBR) upgraded at Dahlman to Buy. $30 price target. Recent management changes should help the company. National Oilwell Varco ( NOV) numbers boosted at Morgan Stanley. Shares of NOV now seen reaching $79. Estimates also upped, given solid rig demand. Equal-weight rating. Newell Rubbermaid ( NWL) numbers increased at Morgan Stanley. NWL estimates were raised through 2013. Company is cutting costs and has better earnings visibility. News Corp. ( NWSA) rated new Neutral at UBS. $19 price target. Ad recovery moderating. Olin ( OLN) downgraded at BofA Merrill from Buy to Underperform. $24 price target. Weaker volume outlook and limited upside to chlor-alkali prices.